BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 34251953)

  • 1. Prognostic value of liver stiffness measurement in patients with hepatocellular carcinoma (HCC) treated by radiofrequency ablation: a meta-analysis.
    Zhang Y; Chen H; Chen S; Li W
    Int J Hyperthermia; 2021; 38(1):1052-1059. PubMed ID: 34251953
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Liver stiffness measured by acoustic radiation force impulse elastography predicted prognoses of hepatocellular carcinoma after radiofrequency ablation.
    Lee PC; Chiou YY; Chiu NC; Chen PH; Liu CA; Kao WY; Huo TI; Huang YH; Hou MC; Lin HC; Wu JC; Su CW
    Sci Rep; 2020 Feb; 10(1):2006. PubMed ID: 32029840
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of acoustic radiation force impulse elastography and transient elastography for prediction of hepatocellular carcinoma recurrence after radiofrequency ablation.
    Yoon JS; Lee YR; Kweon YO; Tak WY; Jang SY; Park SY; Hur K; Park JG; Lee HW; Chun JM; Han YS; Lee WK
    Eur J Gastroenterol Hepatol; 2018 Oct; 30(10):1230-1236. PubMed ID: 29794814
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Can Liver Ultrasound Elastography Predict the Risk of Hepatocellular Carcinoma Recurrence After Radiofrequency Ablation? A Systematic Review and Meta-Analysis.
    Vestito A; Dajti E; Cortellini F; Montagnani M; Bazzoli F; Zagari RM
    Ultraschall Med; 2023 Jun; 44(3):e139-e147. PubMed ID: 34758491
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Liver stiffness measured by MR elastography is a predictor of early HCC recurrence after treatment.
    Cho HJ; Kim B; Kim HJ; Huh J; Kim JK; Lee JH; Seo CW; Ahn HR; Eun JW; Kim SS; Cho SW; Cheong JY
    Eur Radiol; 2020 Aug; 30(8):4182-4192. PubMed ID: 32189053
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Using transient elastography to predict hepatocellular carcinoma recurrence after radiofrequency ablation.
    Lee YR; Park SY; Kim SU; Jang SY; Tak WY; Kweon YO; Kim BK; Park JY; Kim DY; Ahn SH; Han KH; Hur K
    J Gastroenterol Hepatol; 2017 May; 32(5):1079-1086. PubMed ID: 27859615
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prognosis value of liver stiffness measurements by 2D-SWE in primary HBV-positive hepatocellular carcinoma following radiofrequency ablation.
    Xie X; Yu Y
    Transl Cancer Res; 2020 Apr; 9(4):2518-2526. PubMed ID: 35117611
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Liver stiffness measurement changes following hepatocellular carcinoma treatment with percutaneous microwave ablation or transarterial chemoembolization: a cohort study.
    Abdelaziz AO; Abdelhalim H; Elsharkawy A; Shousha HI; Abdelmaksoud AH; Soliman ZA; Seif MI; Sayed DB; Farouk MH; Elbaz TM; Nabeel MM
    Eur J Gastroenterol Hepatol; 2019 Jun; 31(6):685-691. PubMed ID: 30640743
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Role of liver and spleen stiffness in predicting the recurrence of hepatocellular carcinoma after resection.
    Marasco G; Colecchia A; Colli A; Ravaioli F; Casazza G; Bacchi Reggiani ML; Cucchetti A; Cescon M; Festi D
    J Hepatol; 2019 Mar; 70(3):440-448. PubMed ID: 30389551
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Radiofrequency ablation versus hepatic resection for small hepatocellular carcinoma: a meta-analysis of randomized controlled trials.
    Qi X; Tang Y; An D; Bai M; Shi X; Wang J; Han G; Fan D
    J Clin Gastroenterol; 2014; 48(5):450-7. PubMed ID: 24172183
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Liver resection versus radiofrequency ablation for recurrent hepatocellular carcinoma: a systematic review and meta-analysis.
    Yang Y; Yu H; Tan X; You Y; Liu F; Zhao T; Qi J; Li J; Feng Y; Zhu Q
    Int J Hyperthermia; 2021; 38(1):875-886. PubMed ID: 34078221
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Individual or combined transcatheter arterial chemoembolization and radiofrequency ablation for hepatocellular carcinoma: a time-to-event meta-analysis.
    Jiang C; Cheng G; Liao M; Huang J
    World J Surg Oncol; 2021 Mar; 19(1):81. PubMed ID: 33741001
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Survival comparison between radiofrequency ablation and surgical resection for patients with small hepatocellular carcinoma: A systematic review and meta-analysis.
    Xuan D; Wen W; Xu D; Jin T
    Medicine (Baltimore); 2021 Feb; 100(7):e24585. PubMed ID: 33607788
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Liver stiffness is associated with risk of decompensation, liver cancer, and death in patients with chronic liver diseases: a systematic review and meta-analysis.
    Singh S; Fujii LL; Murad MH; Wang Z; Asrani SK; Ehman RL; Kamath PS; Talwalkar JA
    Clin Gastroenterol Hepatol; 2013 Dec; 11(12):1573-84.e1-2; quiz e88-9. PubMed ID: 23954643
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Transient elastography predicts survival after radiofrequency ablation of hepatocellular carcinoma developing on cirrhosis.
    Rekik S; Allaire M; Mumana A; Guyot E; Nkontchou G; Grando V; Blaise L; Ziol M; Nahon P; Ganne-Carrié N; Sutter O; Seror O; Nault JC
    J Gastroenterol Hepatol; 2020 Jan; 35(1):142-150. PubMed ID: 31237018
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Radiofrequency Ablation Combined with Transcatheter Arterial Chemoembolization Therapy Versus Surgical Resection for Hepatocellular Carcinoma within the Milan Criteria: A Meta-Analysis.
    Wang WD; Zhang LH; Ni JY; Jiang XY; Chen D; Chen YT; Sun HL; Luo JH; Xu LF
    Korean J Radiol; 2018; 19(4):613-622. PubMed ID: 29962868
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prognostic value of enhancement rate by enhanced ultrasound in hepatitis B virus-positive hepatocellular carcinoma undergoing radiofrequency ablation.
    Zhou G; Cai ZQ; Luo J; Hu ZX; Luo H; Wu H; Chen Q
    Asia Pac J Clin Oncol; 2019 Aug; 15(4):238-243. PubMed ID: 31119840
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Long-term survival of hepatocellular carcinoma after percutaneous radiofrequency ablation guided by ultrasound.
    Zhang W; Luo E; Gan J; Song X; Bao Z; Zhang H; Chen M
    World J Surg Oncol; 2017 Jul; 15(1):122. PubMed ID: 28679433
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prediction of recurrence after curative resection of hepatocellular carcinoma using liver stiffness measurement (FibroScan®).
    Jung KS; Kim SU; Choi GH; Park JY; Park YN; Kim DY; Ahn SH; Chon CY; Kim KS; Choi EH; Choi JS; Han KH
    Ann Surg Oncol; 2012 Dec; 19(13):4278-86. PubMed ID: 22752370
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prognostic value of liver stiffness measurement for the liver-related surgical outcomes of patients under hepatic resection: A meta-analysis.
    Huang Z; Huang J; Zhou T; Cao H; Tan B
    PLoS One; 2018; 13(1):e0190512. PubMed ID: 29324802
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.